dermatitis
Information
- Disease name
- dermatitis
- Disease ID
- DOID:2723
- Description
- "A skin disease characterized by itchy, erythematous, vesicular, weeping and crusting patches of skin." [url:http\://en.wikipedia.org/wiki/Dermatitis, url:http\://www.nlm.nih.gov/medlineplus/eczema.html]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04057950 | Completed | N/A | Effects on the Scalp Microbiota of a 1% Selenium Disulfide and 1% Salicylic Acid Shampoo After 2% Ketaconazole Foaming Gel Treatment for Scalp Seborrheic Dermatitis | June 1, 2019 | March 1, 2021 |
| NCT00005781 | Completed | Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles | May 2000 | September 2000 | |
| NCT02558738 | Completed | Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations | June 2015 | September 2015 | |
| NCT02615912 | Completed | N/A | A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants | November 2015 | February 2016 |
| NCT02724449 | Completed | N/A | A Clinical Evaluation of 3M Cavilon Advanced Barrier Film for the Treatment of Incontinence Associated Dermatitis (IAD) | August 2014 | February 2015 |
| NCT02916888 | Completed | A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists | September 2016 | December 2017 | |
| NCT02979210 | Completed | N/A | Infant Fecal Insult Study | November 2016 | February 1, 2017 |
| NCT03073837 | Completed | N/A | Rudolph: Nasal Microbiota With Red and Sore Nose | March 20, 2017 | August 15, 2017 |
| NCT03242577 | Completed | Micro-Technique Sampling | August 1, 2017 | August 2, 2017 | |
| NCT03474874 | Completed | N/A | Human Repeated Insult Patch Test | February 26, 2018 | April 6, 2018 |
| NCT03563066 | Completed | Phase 2 | Effect of Benralizumab in Atopic Dermatitis | September 4, 2018 | September 28, 2021 |
| NCT03627767 | Completed | Phase 3 | Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects | June 11, 2018 | October 7, 2020 |
| NCT03706040 | Completed | Phase 2 | A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis | December 27, 2018 | April 26, 2021 |
| NCT03720470 | Completed | Phase 3 | Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy | October 29, 2018 | March 6, 2020 |
| NCT00001150 | Completed | Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers | October 1976 | March 2004 | |
| NCT04760314 | Completed | Phase 3 | A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis | March 10, 2021 | February 1, 2023 |
| NCT04772482 | Completed | Study on Hypoallergenic Hair Dye | April 1, 2021 | May 13, 2022 | |
| NCT04826471 | Completed | N/A | Clinical Investigation on the Performance and Safety of DermoRelizema Ecofoam | May 13, 2021 | January 5, 2022 |
| NCT05001139 | Completed | N/A | Clinical Investigation on the Efficacy and Safety of Relizema Ecofoam | November 15, 2021 | June 15, 2023 |
| NCT05247333 | Completed | N/A | Implementation of a Minor Ailment Service in Community Pharmacy Practice | October 1, 2020 | September 30, 2023 |
| NCT05324618 | Completed | Phase 4 | Tacrolimus Versus Hydrocortisone in Atopic Dermatitis | May 15, 2022 | April 30, 2023 |
| NCT05414552 | Completed | ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment | June 1, 2021 | December 30, 2022 | |
| NCT05699122 | Completed | N/A | Use of Low-level Laser Therapy in the Treatment of Incontinence-associated Dermatitis in the Elderly | February 1, 2023 | June 30, 2023 |
| NCT00375713 | Completed | Phase 3 | Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema | October 2005 | May 2006 |
| NCT00667056 | Completed | Phase 4 | Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis | July 2004 | December 2004 |
| NCT00748319 | Completed | N/A | Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma | March 2009 | December 2011 |
| NCT00801502 | Completed | N/A | Salmon in Pregnancy Study | May 2007 | March 2012 |
| NCT00868036 | Completed | Evaluating for Contact Allergies in Patients With Chronic Urticaria | December 2008 | January 2011 | |
| NCT00894712 | Completed | Topical Application of Sulforaphane-containing Broccoli Sprout Extracts on Radiation Dermatitis | April 15, 2009 | November 15, 2012 | |
| NCT01259323 | Completed | Phase 1 | Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis | December 2010 | July 2012 |
| NCT01762020 | Completed | Phase 3 | Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation | January 2013 | February 2017 |
| NCT01840605 | Completed | Phase 3 | A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis | March 2013 | November 2013 |
| NCT01910662 | Completed | Phase 1 | Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD) | February 22, 2013 | November 26, 2013 |
| NCT01916980 | Completed | Phase 3 | Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202) | August 27, 2013 | March 22, 2014 |
| NCT02115399 | Completed | ADRN Barrier/Immunoprofiling Exploratory Pilot Study | April 2014 | June 2015 | |
| NCT02447393 | Completed | Phase 1 | Phase 1 Study of Levocetirizine | March 18, 2008 | April 30, 2008 |
| NCT05611346 | Not yet recruiting | N/A | HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers | April 2024 | May 2027 |
| NCT06353087 | Not yet recruiting | Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) | April 1, 2024 | November 15, 2025 | |
| NCT01631617 | Recruiting | Phase 2 | Effects of Treatments on Atopic Dermatitis | September 18, 2012 | January 1, 2025 |
| NCT06436183 | Recruiting | Phase 2 | A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis | May 1, 2024 | June 2025 |
| NCT03024671 | Recruiting | N/A | Epicutaneous Testing of Cosmetics for Skin Compatibility | February 10, 2017 | December 2025 |
| NCT05891743 | Recruiting | Prevalence of Skin Sensitization and Dermatitis Among Epoxy-exposed Workers in the Wind Turbine Industry. | March 8, 2024 | August 7, 2024 | |
| NCT00176956 | Terminated | Phase 3 | Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients | November 2002 | January 2007 |
| NCT00217009 | Terminated | Early Phase 1 | Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases. | March 2005 | November 2008 |
| NCT00421161 | Unknown status | Phase 1/Phase 2 | Olive Oil With Omega 3 to Treat Stasis Dermatitis | January 2007 | March 2007 |
| NCT02761408 | Unknown status | ALDH2 Mutation in Taiwanese Head and Neck Cancer | April 2016 | July 2018 | |
| NCT01012453 | Unknown status | N/A | A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema | October 2009 | |
| NCT02580279 | Unknown status | Phase 2 | Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy | December 2014 | October 2019 |
| NCT01816542 | Unknown status | N/A | Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests | June 2013 | September 2013 |
| NCT03046810 | Unknown status | N/A | Treatment of Incontinence Associated Dermatitis - Automated | April 1, 2017 | September 2019 |
| NCT03051321 | Unknown status | N/A | Maintaining Lower Levels of Care Through Automated Perineal Hygiene | April 1, 2017 | October 2018 |
| NCT01239719 | Unknown status | Phase 3 | Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis | March 2011 | December 2011 |
| NCT03493724 | Unknown status | Interest of Photographs by Smartphone in Dermatology | February 13, 2018 | September 1, 2018 | |
| NCT01125761 | Withdrawn | Phase 3 | Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis | November 2010 | November 2010 |
| NCT00746382 | Withdrawn | Phase 2 | A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM) | November 2008 | September 2009 |
| NCT04325802 | Withdrawn | Phase 2 | Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone | December 31, 2022 | June 2024 |
| NCT04154033 | Withdrawn | Phase 2 | Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone | October 1, 2020 | March 31, 2024 |
- Disase is a (Disease Ontology)
- DOID:37
- Cross Reference ID (Disease Ontology)
- ICD10CM:L30.9
- Cross Reference ID (Disease Ontology)
- MESH:D003872
- Cross Reference ID (Disease Ontology)
- NCI:C2983
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:238538009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0011603
- Exact Synonym (Disease Ontology)
- eczema
- Exact Synonym (Disease Ontology)
- skin inflammation
- MeSH unique ID (MeSH (Medical Subject Headings))
- D003872